The WACC of China Biologic Products Holdings Inc (CBPO) is 7.4%.
| Range | Selected | |
| Cost of equity | 7.60% - 13.70% | 10.65% |
| Tax rate | 15.90% - 16.30% | 16.10% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.9% - 8.9% | 7.4% |
| Category | Low | High |
| Long-term bond rate | 3.2% | 3.7% |
| Equity market risk premium | 4.2% | 5.2% |
| Adjusted beta | 1.04 | 1.82 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.60% | 13.70% |
| Tax rate | 15.90% | 16.30% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.9% | 8.9% |
| Selected WACC | 7.4% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for CBPO:
cost_of_equity (10.65%) = risk_free_rate (3.45%) + equity_risk_premium (4.70%) * adjusted_beta (1.04) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.